Tristel (TSTL) Competitors

Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment, community ranking and dividends.

Which has more risk and volatility, AMS or TSTL?

Advanced Medical Solutions Group has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500.

Which has preferable valuation & earnings, AMS or TSTL?

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£132.18M	3.24	£11.22M	£5.16	38.48
Tristel	£42.24M	4.05	£6.54M	£13.66	26.21

Is AMS or TSTL a better dividend stock?

Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.6%. Advanced Medical Solutions Group pays out 38.8% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Do insiders & institutionals believe in AMS or TSTL?

58.2% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 50.4% of Tristel shares are owned by institutional investors. 3.1% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 4.9% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media prefer AMS or TSTL?

In the previous week, Advanced Medical Solutions Group had 3 more articles in the media than Tristel. MarketBeat recorded 4 mentions for Advanced Medical Solutions Group and 1 mentions for Tristel. Tristel's average media sentiment score of 0.67 beat Advanced Medical Solutions Group's score of 0.65 indicating that Tristel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Medical Solutions Group	1 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tristel	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community favor AMS or TSTL?

Advanced Medical Solutions Group received 19 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 50.15% of users gave Advanced Medical Solutions Group an outperform vote.

Company	Underperform	Outperform
Advanced Medical Solutions Group	Outperform Votes 167 50.15%	Underperform Votes 166 49.85%
Tristel	Outperform Votes 148 57.36%	Underperform Votes 110 42.64%

Is AMS or TSTL more profitable?

Tristel has a net margin of 15.47% compared to Advanced Medical Solutions Group's net margin of 8.49%. Tristel's return on equity of 20.43% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	8.49%	4.57%	2.35%
Tristel	15.47%	20.43%	9.89%

Do analysts rate AMS or TSTL?

Advanced Medical Solutions Group currently has a consensus target price of GBX 300, suggesting a potential upside of 51.09%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tristel	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Advanced Medical Solutions Group beats Tristel on 11 of the 20 factors compared between the two stocks.